Skip to main content

Advertisement

Table 1 Availability of medicines for diabetes and hypertension

From: Medicines availability for non-communicable diseases: the case for standardized monitoring

Medicine Mean availability (%) of medicine
Peck et al. WHO/HAI SARA
All facilities# Diabetes services Cardiovascular disease services
N = 24 N = 107 N = 1297 N = 248 N = 316
Diabetes      
Glibenclamide   47* 19* 52  
Metformin 33 46†   57 39
Insulin 17; 8; 8‡    34  
Hypertension      
Captopril 25 mg   48 13   
Captopril or lisinopril 25     
ACE inhibitors      24
Nifedipine 33 57§    
Calcium channel blockers      29
Atenolol 50 mg   48 15   
Atenolol or propranolol 50     
Beta-blockers      41
Hydrochlorothiazide or bendrofluazide 33     31¥
  1. FBO = Faith Based Organization; SR = sustained release formulation.
  2. #Availability of essential tracer medicines is measured across all health facilities surveyed.
  3. *glibenclamide 5 mg tablet.
  4. †metformin 500 mg tablet.
  5. ‡short-acting, intermediate-acting and long-acting insulin assessed separately.
  6. §WHO/HAI survey specified 20 mg sustained-release formulation.
  7. ¥specified as thiazide diuretics.